
BKIT
Healthcare · Drug Manufacturers - Specialty & Generic · $4,974 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 31, 2019 | Time not confirmed | — | -0.02 | — |
| Feb 28, 2019 | Time not confirmed | — | -0.36 | — |
| Nov 30, 2018 | Time not confirmed | — | -0.25 | — |
| Aug 31, 2018 | Time not confirmed | — | -0.59 | — |
| May 31, 2018 | Time not confirmed | — | -0.49 | — |
| Feb 28, 2018 | Time not confirmed | — | -0.12 | — |
BioHemp International, Inc. focuses on operating in the fast-growing consumer hemp and cannabidiol (CBD) market through a strategic rollup of CBD distributors. It focuses on the creation of distribution platform for CBD providers. The company was formerly known as Blake Insomnia Therapeutics, Inc. and changed its name to BioHemp International, Inc. in June 2019. BioHemp International, Inc. was founded in 2012 and…